Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Skeletal function and structure: implications for tissue-targeted therapeutics.

Jill E Shea1, Scott C Miller

  • 1Division of Radiobiology, University of Utah, 729 Arapeen Drive, Salt Lake City, UT 84108, USA.

Advanced Drug Delivery Reviews
|May 7, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

FOLR1-targeted actinium-225-based alpha-particle therapy eliminates ovarian cancer.

Science advances·2026
Same author

Potential predictors of hip surgery following selective dorsal rhizotomy in children with cerebral palsy: Survival analysis of a retrospective cohort.

PM & R : the journal of injury, function, and rehabilitation·2026
Same author

Determining the Biological Variability of Daily Amount of Feces to Estimate Dose Uncertainties Based on Data from Mayak Plutonium Workers.

Health physics·2026
Same author

FOLR1-targeted Actinium-225-based Alpha-particle Therapy Eliminates Ovarian Cancer.

bioRxiv : the preprint server for biology·2025
Same author

Angiosarcoma of the Liver and Other Hepatic Malignancies in the Russian Cohort of Mayak Nuclear Workers.

Radiation research·2025
Same author

Author Correction: Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancers.

Nature medicine·2025
Same journal

Silicone oil in protein drug products and its implications for formulation stability.

Advanced drug delivery reviews·2026
Same journal

Targeted delivery of proteolysis-targeting chimeras (PROTAC) and molecular glue degraders (MGD).

Advanced drug delivery reviews·2026
Same journal

Lysosome-targeting degrader delivery system: from formulation design to biomedical applications.

Advanced drug delivery reviews·2026
Same journal

Anti-PEG antibodies in nanomedicine: Mechanisms, risks, and opportunities.

Advanced drug delivery reviews·2026
Same journal

Optimizing macrophage-targeted intracellular delivery systems for safe and effective immunotherapies.

Advanced drug delivery reviews·2026
Same journal

Light-controlled CRISPR-dCas9 epigenome editing: advanced drug-delivery strategies and oncology applications.

Advanced drug delivery reviews·2026
See all related articles

New therapeutic strategies for skeletal diseases like osteoporosis can leverage bone

Area of Science:

  • Skeletal Biology and Pharmacology
  • Biomaterials and Drug Delivery

Background:

  • Common skeletal diseases include osteoporosis, arthritis, and periodontal disease, necessitating novel therapeutic approaches.
  • Bone is a dynamic tissue capable of repair and response to mechanical and endocrine stimuli.
  • Bone physiology presents unique challenges and opportunities for targeted drug delivery.

Purpose of the Study:

  • To explore the potential of exploiting bone's physiological characteristics for targeted drug delivery.
  • To identify key factors influencing the success of pharmacological treatments for skeletal diseases.

Main Methods:

  • Review of bone physiology, including remodeling, vascularization, and the blood-bone barrier.
  • Analysis of bone's structural properties, such as hydroxyapatite crystals and mineral binding.

Related Experiment Videos

  • Consideration of targeting strategies based on bone surface activity.

    • Main Results:

    • Bone remodeling heterogeneity, vascularization, and the blood-bone barrier impact drug delivery efficacy.
    • Bone mineral's affinity for molecules like bisphosphonates offers a mechanism for targeted delivery.
    • Distinct bone surface activities (inactive, forming, resorbing) present opportunities for site-specific targeting.

    Conclusions:

    • Understanding and utilizing bone's physiological characteristics are crucial for developing effective bone-targeted therapies.
    • Targeted drug delivery holds promise for treating common skeletal diseases.